(3-(Ethylsulfonamido)phenyl)boronic acid – (710348-41-7)

76778-22-8, Gbr 12935, GBR-12935, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine, GBR12935, 1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine, 1-(2-(benzhydryloxy)ethyl)-4-(3-phenylpropyl)piperazine, 1-(2 (Diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine, GBR-12935 free base, CHEMBL26320, 9J9974WIBA, CHEBI:64093, 76778-22-8 (free base), 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine, Piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)-, Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-, UNII-9J9974WIBA, [3H]GBR12935, [3H]-GBR12935, 1-(2-Diphenylmethoxyethyl)-4-(3-phenylpropyl)piperazinedihydrochloride, Tocris-0514, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine maleate, Lopac-G-9659, Biomol-NT_000056, Lopac0_000560, MLS006012605, SCHEMBL726349, BPBio1_001315, GTPL4638, GTPL4639, 1-hydrocinnamyl-4-(2-(diphenylmethoxy)ethyl)piperazine, DTXSID2043743, BDBM22167, BCP02704, HY-12242A, AKOS028110061, CCG-204650, CS-3131, FG65031, SDCCGSBI-0050543.P002, NCGC00015484-01, NCGC00015484-02, NCGC00015484-03, NCGC00015484-04, NCGC00015484-05, NCGC00015484-06, NCGC00024628-01, NCGC00024628-02, NCGC00024628-03, DA-73669, SMR004704148, J227.604F, D87612, Q5512952, BRD-K50135270-001-01-9, BRD-K50135270-300-01-5, BRD-K50135270-300-02-3